Send Enquiry

CURE
Tablets
Packaging and packing Type
Blister | 10x15
MRP :
₹112
PTR :
₹85.33
PTS :
₹76.8
Prescription medicine Read More
Composition
Send Enquiry
Available on PCD franchise with monopoly rights: Cardiac and diabetic PCD franchise
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Viglim MP1 is an oral anti-diabetic tablet from Vibcare Pharma. Each tablet has Glimepiride 1 mg, Pioglitazone 15 mg and Metformin 500 mg, in the anti-diabetic class. Supplied as Tablets, packed as 10x15 (Blister).
Glimepiride pushes the pancreas to release more insulin. Pioglitazone reduces insulin resistance in the liver and body tissues. Metformin reduces glucose made by the liver and improves the body's response to insulin. Together they support blood sugar control when diet and exercise alone are not enough.
Viglim MP1 is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. Pioglitazone can cause or worsen heart failure; patients must be watched closely for signs such as rapid weight gain, breathlessness and swelling after starting the tablet and after any dose increase. If liver injury appears, pioglitazone must be stopped promptly and the patient assessed for its probable cause. Metformin can rarely cause lactic acidosis, and the risk is higher with kidney problems, age 65 or above, heavy drinking, contrast dye X-ray studies, surgery, low-oxygen states, liver problems and some other medicines. Glimepiride may cause severe low blood sugar and hemolytic anemia in G6PD deficiency.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
For distributors and medical representatives
Viglim MP1 Tablet is part of Vibcare Pharma's cardiac and diabetic range. Take the range to your area as a PCD franchise partner, with monopoly rights in your district.
Cardiac and diabetic PCD franchisePCD pharma franchise with Vibcare
Viglim MP1 tablets combine glimepiride, pioglitazone and metformin for blood sugar control in adults with type 2 diabetes. Main uses: adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus; for patients whose sugar is not controlled well enough by diet, exercise and a single medicine; helps lower blood glucose when the body still makes its own insulin; complements diet and exercise as part of a diabetes care plan.
Common side effects of Viglim MP1 Tablet include low blood sugar (hypoglycemia); headache and dizziness; nausea and loose motions (diarrhoea); upper respiratory tract infection; muscle pain (myalgia); swelling (edema) and weight gain. Get medical help at once if you notice severe low blood sugar; lactic acidosis, a rare but serious build-up of lactic acid in the blood linked to metformin; congestive heart failure or worsening of existing heart failure linked to pioglitazone.
Each Viglim MP1 tablet contains Glimepiride 1 mg + Pioglitazone 15 mg + Metformin 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Viglim MP1 Tablet only as your doctor advises.
The MRP of Viglim MP1 Tablet is ₹112 for a pack of 10x15 (Blister). For chemists and distributors, the PTR is ₹85.33 and the PTS is ₹76.8.
Each Viglim MP1 tablet contains Glimepiride 1 mg + Pioglitazone 15 mg + Metformin 500 mg. It comes in a pack of 10x15 (Blister).
Glimepiride pushes the pancreas to release more insulin. Pioglitazone reduces insulin resistance in the liver and body tissues. Metformin reduces glucose made by the liver and improves the body's response to insulin. Together they support blood sugar control when diet and exercise alone are not enough.
Must not be used for type 1 diabetes mellitus or diabetic ketoacidosis. Must not be used if you have severe kidney impairment (eGFR below 30 mL/min/1.73 m²) or metabolic acidosis. Do not initiate in patients with established NYHA Class III or IV heart failure. Must not be used if you are allergic to glimepiride, sulfonamide derivatives, pioglitazone, metformin or any of the tablet's ingredients. Must not be used if you have active bladder cancer; check with a doctor first if you have had bladder cancer earlier. Check with a doctor first if you have liver disease, kidney problems, G6PD deficiency, heart failure, drink alcohol heavily, or are elderly.
Viglim MP1 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner